
An oral rapid-dissolving tablet form of tirzepatide for appetite regulation, glucose control, and weight management — no injection.
Tirzepatide is a synthetic peptide engineered to activate both GIP and GLP-1 receptors.
The oral RDT delivers the same active molecule through buccal absorption.
GLP-1 receptor activation slows gastric emptying and increases satiety.
GIP receptor activation enhances insulin secretion and modulates fat metabolism.
For educational reference only — not medical advice. Loop does not diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Your protocol is built with a licensed Loop clinician based on your goals, history, and labs.